Emcure Pharmaceuticals has inaugurated its recently commissioned facility at Mehsana in Gujarat. The inauguration was done by Rushikeshbhai Patel, Minister of Health and Family Welfare, Gujarat. The new plant manufactures injectables for sale in India as well as for export to global markets.

Emcure's manufacturing operations have been established for decades, and are spread across 13 sites in India. The company currently has an oral formulations manufacturing line at Mehsana and the new unit commissioned in August, 2023 is now ready for commercial supplies to domestic and international markets.

With dedicated manufacturing facilities for different platforms and packaging formats, Emcure’s manufacturing facilities across the country are capable of producing pharmaceutical and biopharmaceutical products across a wide range of dosage forms, including oral solids, oral liquids, injectables, including liposomal and lyophilised injectables, biotherapeutics and complex APIs.

With approvals and accreditations from various regulatory authorities such as EDQM, Health Canada, USFDA, ANVISA Brazil, and more, the company ensures that it remains in compliance with the relevant regulations and is able to supply products in regulated and other markets.

Emcure’s new manufacturing plant will aim at creating additional job opportunities in the local market.